A phospho-proteomic screen identifies novel S6K1 and mTORC1 substrates revealing additional complexity in the

Katarzyna Jastrzebski1, Katherine M Hannan, Colin M House

  • 1Research Division, Peter MacCallum Cancer Centre, Melbourne, Locked Bag 1, A'Beckett Street, Victoria 8006, Australia.

Cellular Signalling
|March 29, 2011
PubMed

Insights

The nuclear p85 ribosomal S6 kinase 1 (S6K1) isoform

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Ribosomal protein S6 kinase 1 (S6K1) is a key mediator of mTORC1 signaling, regulating cell growth and protein synthesis.
  • While the cytoplasmic p70(S6K1) isoform's role in translation is well-established, the nuclear p85(S6K1) isoform's functions and substrates remain largely unknown.

Purpose of the Study:

  • To identify novel nuclear p85(S6K1) substrates using a phospho-proteomic screen.
  • To elucidate the functional consequences of p85(S6K1) phosphorylation on its substrates.

Main Methods:

  • Phospho-proteomic screening to identify p85(S6K1) targets.
  • Site-directed mutagenesis and in vitro assays to investigate phosphorylation site function.
  • Biochemical assays to assess chaperonin folding activity.

Main Results:

  • Identified four novel p85(S6K1) substrates (GRP75, CCTβ, PGK1, RACK1) and two mTORC1 substrates (ANXA4, PSMA6).
  • Determined that phosphorylation of the chaperonin subunit CCTβ at serine 260 modulates its folding activity.
  • The identified substrates are involved in diverse cellular processes including chaperone function, metabolism, and proteasome activity.

Conclusions:

  • The nuclear p85(S6K1) isoform phosphorylates diverse proteins involved in fundamental cellular processes.
  • Phosphorylation of CCTβ by p85(S6K1) directly impacts chaperonin folding activity, suggesting a role in regulating protein homeostasis.
  • This study expands the known functions of S6K1 into the nucleus, revealing new regulatory mechanisms in cell growth and protein synthesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...